29 Jan 2018
TissUse and AstraZeneca to use Microphysical systems in drug development
By Staff Writer
TissUse continues their successful collaboration with AstraZeneca to establish relevant Microphysiological System (MPS) models based on TissUse’s Multi-Organ-Chip technology.
